Background
The human SCN5A gene encodes the pore-forming subunit of Nav1.5, a voltage-gated sodium channel expressed in heart and upregulated in breast cancer cells. Mutations in SCN5A are responsible for some forms of long QT and short QT syndromes, progressive cardiac conduction defect, sick sinus node syndrome, and dilated cardiomyopathy, Brugada syndrome, congenital heart block, Nav1.5 channels are anti-targets in cardiac risk assessment.
| General Info | |
| Synonyms | cardiac sodium channel |
|---|---|
| Product Description | Human Nav1.5 sodium ion channel-expressing, stable replicating cell line (HEK). |
| Target Type | Ion Channel |
| Product Type | Replicating Cell Line |
| Family | Sodium, Voltage-Gated |
| Sub-Type | Nav1.5 |
| Class | Voltage-gated sodium channel |
| Therapeutic Area | cancer, cardiac |
| Related Services | Cardiac Ion Channel Panel™, Large-scale Cryopreservation |
| Gene Name | SCN5A |
| Validated Assay/Platform | FLIPR®, manual patch clamp, PatchXpress® |
| References | Catterall WA, et al. 2005. Pharmacol Rev 57:397-409. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels |
| Host cell | HEK293 |
| Mycoplasma Status | Negative (MycoAlert Kit) |
| Storage & Packaging | |
| Packaging | Cryopreserved cells, 1-2x106 cells |
| Storage Recommendation | liquid nitrogen |
| Quantity | 1-2 million cells |
| Product Documentation | |
| Specification Sheet | |



